BEAT

Heartbeam Inc

• TipRanks·16h ago

  HeartBeam (NASDAQ: BEAT) Aims to Close Critical Gap in Early Cardiac Detection

• Dow Jones·4d ago

  Heartbeam Is Maintained at Buy by HC Wainwright & Co.

• Dow Jones·4d ago

  Heartbeam Price Target Cut to $2.50/Share From $5.50 by HC Wainwright & Co.

• Benzinga·4d ago

  HC Wainwright & Co. Maintains Buy on HeartBeam, Lowers Price Target to $2.5

• TipRanks·4d ago

  HeartBeam price target lowered to $2.50 from $5.50 at H.C. Wainwright

• Reuters·4d ago

  HEARTBEAM, INC. <BEAT.O>: H.C. WAINWRIGHT CUTS TARGET PRICE TO $2.5 FROM $5.5

• Reuters·5d ago

  U.S. RESEARCH ROUNDUP-Jazz Pharmaceuticals, Target, Workday

• TipRanks·05/15 14:03

  HeartBeam price target lowered to $5 from $8 at Benchmark

• Dow Jones·05/15 12:47

  Heartbeam Price Target Cut to $5.00/Share From $8.00 by Benchmark

• Dow Jones·05/15 12:47

  Heartbeam Is Maintained at Speculative Buy by Benchmark

• Benzinga·05/15 12:37

  Benchmark Maintains Speculative Buy on HeartBeam, Lowers Price Target to $5

• TipRanks·05/15 00:13

  HeartBeam Earnings Call: Funding Extends Runway, Trials Advance

• TipRanks·05/14 18:30

  HeartBeam (NASDAQ: BEAT) Advances Commercial Launch, Reports First-Quarter 2026 Results

• Benzinga·05/13 21:35

  HeartBeam Q1 2026 Earnings Call: Complete Transcript

• Seeking Alpha·05/13 20:53

  HeartBeam GAAP EPS of -$0.12 beats by $0.02